PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1281168-4 1992 Specifically, in tumor necrosis factor (TNF)-treated immunocytes, we demonstrate the effects of increased NEP expression on altering the stimulatory activities of the neuropeptides met-enkephalin, melanocyte-stimulating hormone and substance P. We demonstrate the significance of NEP in modulating these responses through the use of specific enzyme inhibitors such as phosphoramidon, thiorphan and captopril. phosphoramidon 368-382 tumor necrosis factor Homo sapiens 17-38 1281168-4 1992 Specifically, in tumor necrosis factor (TNF)-treated immunocytes, we demonstrate the effects of increased NEP expression on altering the stimulatory activities of the neuropeptides met-enkephalin, melanocyte-stimulating hormone and substance P. We demonstrate the significance of NEP in modulating these responses through the use of specific enzyme inhibitors such as phosphoramidon, thiorphan and captopril. phosphoramidon 368-382 tumor necrosis factor Homo sapiens 40-43 9533826-7 1998 Pre-treatment with phosphoramidon (1 micron) an ECE-inhibitor, followed by TNF-alpha stimulation, decreased ir-ET-1 levels. phosphoramidon 19-33 tumor necrosis factor Homo sapiens 75-84